|
|
| FURIN_HUMAN |
FURIN |
Furin |
3.522e-182 |
0.57
|
| PCSK6_HUMAN |
PCSK6 |
Proprotein convertase subtilisin/kexin type 6 |
1.012e-158 |
0.57
|
| C3AR_HUMAN |
C3AR1 |
C3a anaphylatoxin chemotactic receptor |
2.716e-148 |
0.52
|
| WDR5_HUMAN |
WDR5 |
WD repeat-containing protein 5 |
7.446e-141 |
0.67
|
| PAR2_HUMAN |
F2RL1 |
Proteinase-activated receptor 2 |
2.188e-124 |
0.42
|
| Q8I6Z5_PLAF7 |
|
Plasmepsin V |
2.103e-121 |
0.53
|
| MC4R_MOUSE |
Mc4r |
Melanocortin receptor 4 |
4.494e-114 |
0.50
|
| MC5R_MOUSE |
Mc5r |
Melanocortin receptor 5 |
2.915e-111 |
0.50
|
| MSHR_MOUSE |
Mc1r |
Melanocyte-stimulating hormone receptor |
3.255e-110 |
0.50
|
| MC3R_MOUSE |
Mc3r |
Melanocortin receptor 3 |
7.332e-107 |
0.50
|
| POLG_WNV |
|
Genome polyprotein |
3.453e-102 |
0.42
|
| ST14_MOUSE |
St14 |
Suppressor of tumorigenicity 14 protein homolog |
4.503e-102 |
0.43
|
| QRFPR_HUMAN |
QRFPR |
Pyroglutamylated RF-amide peptide receptor |
6.418e-102 |
0.47
|
| TMPS6_HUMAN |
TMPRSS6 |
Transmembrane protease serine 6 |
7.817e-95 |
0.47
|
| NPFF1_HUMAN |
NPFFR1 |
Neuropeptide FF receptor 1 |
6.651e-94 |
0.45
|
| NPFF2_HUMAN |
NPFFR2 |
Neuropeptide FF receptor 2 |
7.849e-92 |
0.45
|
| HGFA_HUMAN |
HGFAC |
Hepatocyte growth factor activator |
3.321e-83 |
0.47
|
| NEC1_HUMAN |
PCSK1 |
Neuroendocrine convertase 1 |
2.808e-82 |
0.44
|
| PCSK5_HUMAN |
PCSK5 |
Proprotein convertase subtilisin/kexin type 5 |
2.808e-82 |
0.44
|
| CHIA_SERMA |
chiA |
Chitinase A |
2.073e-77 |
0.45
|
| SIR1_HUMAN |
SIRT1 |
NAD-dependent protein deacetylase sirtuin-1 |
2.917e-74 |
0.50
|
| BXA1_CLOBH |
botA |
Botulinum neurotoxin type A |
5.007e-74 |
0.46
|
| KISSR_HUMAN |
KISS1R |
KiSS-1 receptor |
1.877e-69 |
0.38
|
| NEC2_HUMAN |
PCSK2 |
Neuroendocrine convertase 2 |
3.771e-69 |
0.44
|
| CFAB_HUMAN |
CFB |
Complement factor B |
1.439e-67 |
0.64
|
| HEPS_HUMAN |
HPN |
Serine protease hepsin |
1.116e-66 |
0.47
|
| CBX7_HUMAN |
CBX7 |
Chromobox protein homolog 7 |
1.537e-59 |
0.39
|
| TPP2_HUMAN |
TPP2 |
Tripeptidyl-peptidase 2 |
2.735e-54 |
0.43
|
| NTR2_HUMAN |
NTSR2 |
Neurotensin receptor type 2 |
2.344e-52 |
0.42
|
| ST14_HUMAN |
ST14 |
Suppressor of tumorigenicity 14 protein |
6.049e-51 |
0.47
|
| GSTA2_HUMAN |
GSTA2 |
Glutathione S-transferase A2 |
2.707e-50 |
0.32
|
| GSP_CRIFA |
GSP |
Glutathionylspermidine synthase |
4.641e-50 |
0.35
|
| PCSK7_HUMAN |
PCSK7 |
Proprotein convertase subtilisin/kexin type 7 |
9.777e-50 |
0.44
|
| NPY4R_HUMAN |
NPY4R |
Neuropeptide Y receptor type 4 |
3.046e-49 |
0.49
|
| CO2_HUMAN |
C2 |
Complement C2 |
3.639e-49 |
0.39
|
| SIR3_HUMAN |
SIRT3 |
NAD-dependent protein deacetylase sirtuin-3, mitochondrial |
1.4e-47 |
0.50
|
| RIR1_MOUSE |
Rrm1 |
Ribonucleoside-diphosphate reductase large subunit |
1.465e-46 |
0.30
|
| POLG_DEN26 |
|
Genome polyprotein |
3.373e-45 |
0.44
|
| MRGX1_MOUSE |
Mrgprx1 |
Mas-related G-protein coupled receptor member X1 |
9.177e-43 |
0.43
|
| GNPAT_HUMAN |
GNPAT |
Dihydroxyacetone phosphate acyltransferase |
1.148e-42 |
0.37
|
| OPRX_MOUSE |
Oprl1 |
Nociceptin receptor |
4.252e-42 |
0.35
|
| HLAA_HUMAN |
HLA-A |
HLA class I histocompatibility antigen, A alpha chain |
7.511e-42 |
0.40
|
| Q91H74_9FLAV |
|
Genome polyprotein |
1.128e-40 |
0.40
|
| OTC_HUMAN |
OTC |
Ornithine carbamoyltransferase, mitochondrial |
5.881e-40 |
0.32
|
| MCA2_TRYBB |
MCA2 |
Metacaspase |
5.906e-40 |
0.34
|
| GSTM1_HUMAN |
GSTM1 |
Glutathione S-transferase Mu 1 |
1.393e-39 |
0.32
|
| SPSB2_HUMAN |
SPSB2 |
SPRY domain-containing SOCS box protein 2 |
8.6e-39 |
0.33
|
| MSHR_HUMAN |
MC1R |
Melanocyte-stimulating hormone receptor |
1.142e-38 |
0.39
|
| Q95WR6_LEIDO |
|
Cysteine protease |
1.507e-37 |
0.47
|
| NTR1_HUMAN |
NTSR1 |
Neurotensin receptor type 1 |
4.204e-36 |
0.42
|
| PADI1_HUMAN |
PADI1 |
Protein-arginine deiminase type-1 |
6.352e-35 |
0.38
|
| GRIA1_RAT |
Gria1 |
Glutamate receptor 1 |
6.399e-35 |
0.32
|
| MC3R_HUMAN |
MC3R |
Melanocortin receptor 3 |
2.257e-34 |
0.39
|
| OPRD_MOUSE |
Oprd1 |
Delta-type opioid receptor |
6.638e-34 |
0.42
|
| SIR2_HUMAN |
SIRT2 |
NAD-dependent protein deacetylase sirtuin-2 |
2.124e-31 |
0.50
|
| OPRM_RAT |
Oprm1 |
Mu-type opioid receptor |
8.941e-31 |
0.43
|
| OPRD_RAT |
Oprd1 |
Delta-type opioid receptor |
9.299e-31 |
0.42
|
| CATZ_RAT |
Ctsz |
Cathepsin Z |
6.531e-30 |
0.37
|
| NMDE1_RAT |
Grin2a |
Glutamate receptor ionotropic, NMDA 2A |
1.058e-29 |
0.32
|
| VM1B1_BOTAS |
|
Snake venom metalloproteinase BaP1 |
1.096e-28 |
0.46
|
| PAR1_HUMAN |
F2R |
Proteinase-activated receptor 1 |
1.152e-28 |
0.43
|
| IDE_HUMAN |
IDE |
Insulin-degrading enzyme |
1.134e-27 |
0.34
|
| ANPRC_HUMAN |
NPR3 |
Atrial natriuretic peptide receptor 3 |
1.995e-27 |
0.34
|
| OPRM_CAVPO |
OPRM1 |
Mu-type opioid receptor |
2.007e-27 |
0.42
|
| MC4R_HUMAN |
MC4R |
Melanocortin receptor 4 |
4.906e-27 |
0.50
|
| Q9NAW4_PLAFA |
|
Cysteine protease falcipain-3 |
7.155e-26 |
0.47
|
| CHIB_SERMA |
chiB |
Chitinase B |
1.657e-25 |
0.35
|
| LGUL_HUMAN |
GLO1 |
Lactoylglutathione lyase |
2.144e-24 |
0.31
|
| PADI3_HUMAN |
PADI3 |
Protein-arginine deiminase type-3 |
3.333e-24 |
0.38
|
| CD36_RAT |
Cd36 |
Platelet glycoprotein 4 |
4.425e-24 |
0.30
|
| S15A2_HUMAN |
SLC15A2 |
Solute carrier family 15 member 2 |
5.245e-24 |
0.30
|
| PADI4_HUMAN |
PADI4 |
Protein-arginine deiminase type-4 |
2.221e-23 |
0.38
|
| ELAS_PSEAE |
lasB |
Elastase |
3.503e-23 |
0.51
|
| CATJ_RAT |
Ctsj |
Cathepsin J |
3.931e-23 |
0.37
|
| NMUR1_HUMAN |
NMUR1 |
Neuromedin-U receptor 1 |
1.398e-20 |
0.31
|
| SIR5_HUMAN |
SIRT5 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial |
2.12e-20 |
0.46
|
| NK1R_RAT |
Tacr1 |
Substance-P receptor |
3.61e-20 |
0.37
|
| MRGX1_RAT |
Mrgprx1 |
Mas-related G-protein coupled receptor member X1 |
7.989e-20 |
0.43
|
| ERAP2_HUMAN |
ERAP2 |
Endoplasmic reticulum aminopeptidase 2 |
8.525e-20 |
0.36
|
| NTR1_MOUSE |
Ntsr1 |
Neurotensin receptor type 1 |
1.115e-19 |
0.34
|
| DPO1_THEAQ |
polA |
DNA polymerase I, thermostable |
1.253e-19 |
0.33
|
| CATC_RAT |
Ctsc |
Dipeptidyl peptidase 1 |
2.68e-19 |
0.37
|
| NMUR2_HUMAN |
NMUR2 |
Neuromedin-U receptor 2 |
4.163e-19 |
0.31
|
| HMDH_MESAU |
HMGCR |
3-hydroxy-3-methylglutaryl-coenzyme A reductase |
4.682e-19 |
0.30
|
| TM11D_HUMAN |
TMPRSS11D |
Transmembrane protease serine 11D |
6.65e-19 |
0.43
|
| NPFF2_RAT |
Npffr2 |
Neuropeptide FF receptor 2 |
9.219e-19 |
0.35
|
| PLMN_BOVIN |
PLG |
Plasminogen |
1.057e-18 |
0.47
|
| CCNA2_HUMAN |
CCNA2 |
Cyclin-A2 |
9.212e-18 |
0.43
|
| OPRK_MOUSE |
Oprk1 |
Kappa-type opioid receptor |
9.308e-18 |
0.39
|
| Q9ERC0_RAT |
Npy2r |
Neuropeptide Y receptor Y2 |
1.006e-17 |
0.28
|
| NK3R_CAVPO |
TACR3 |
Neuromedin-K receptor |
1.139e-17 |
0.35
|
| NPY1R_HUMAN |
NPY1R |
Neuropeptide Y receptor type 1 |
1.11e-16 |
0.42
|
| GSTA1_HUMAN |
GSTA1 |
Glutathione S-transferase A1 |
1.11e-15 |
0.32
|
| KMT2A_HUMAN |
KMT2A |
Histone-lysine N-methyltransferase 2A |
1.11e-15 |
0.30
|
| Q6MGC4_RAT |
Pfdn6 |
H2-K region expressed gene 2, rat orthologue |
1.887e-15 |
0.30
|
| S15A1_HUMAN |
SLC15A1 |
Solute carrier family 15 member 1 |
2.665e-15 |
0.29
|
| LCAP_HUMAN |
LNPEP |
Leucyl-cystinyl aminopeptidase |
2.998e-15 |
0.36
|
| NK2R_MESAU |
TACR2 |
Substance-K receptor |
4.552e-15 |
0.35
|
| NOS3_BOVIN |
NOS3 |
Nitric oxide synthase, endothelial |
4.774e-15 |
0.36
|
| NTR1_RAT |
Ntsr1 |
Neurotensin receptor type 1 |
9.437e-15 |
0.30
|
| NOS2_RAT |
Nos2 |
Nitric oxide synthase, inducible |
1.987e-14 |
0.32
|
| CATH_HUMAN |
CTSH |
Pro-cathepsin H |
4.563e-14 |
0.47
|
| CDYL2_HUMAN |
CDYL2 |
Chromodomain Y-like protein 2 |
7.605e-14 |
0.29
|
| DRB3_HUMAN |
HLA-DRB3 |
HLA class II histocompatibility antigen, DR beta 3 chain |
8.105e-14 |
0.36
|
| CCND1_HUMAN |
CCND1 |
G1/S-specific cyclin-D1 |
1.693e-13 |
0.41
|
| CATL1_HUMAN |
CTSL |
Cathepsin L1 |
1.931e-13 |
0.47
|
| NEP_MOUSE |
Mme |
Neprilysin |
2.482e-13 |
0.29
|
| GLN1B_ECOLI |
glnA |
Glutamine synthetase |
3.922e-13 |
0.29
|
| NK1R_CAVPO |
TACR1 |
Substance-P receptor |
6.223e-13 |
0.35
|
| CATB_BOVIN |
CTSB |
Cathepsin B |
1.495e-12 |
0.47
|
| NOS1_MOUSE |
Nos1 |
Nitric oxide synthase, brain |
1.77e-12 |
0.35
|
| PADI2_HUMAN |
PADI2 |
Protein-arginine deiminase type-2 |
2.558e-12 |
0.36
|
| NRP1_RAT |
Nrp1 |
Neuropilin-1 |
3.05e-12 |
0.30
|
| MMP17_HUMAN |
MMP17 |
Matrix metalloproteinase-17 |
3.653e-12 |
0.31
|
| NOS1_HUMAN |
NOS1 |
Nitric oxide synthase, brain |
3.978e-12 |
0.43
|
| Q9NBA7_PLAFA |
|
Cysteine protease falcipain-3 |
5.439e-12 |
0.32
|
| CATB_RAT |
Ctsb |
Cathepsin B |
6.678e-12 |
0.37
|
| NRP1_HUMAN |
NRP1 |
Neuropilin-1 |
1.115e-11 |
0.31
|
| FA11_HUMAN |
F11 |
Coagulation factor XI |
2.349e-11 |
0.34
|
| GSTP1_HUMAN |
GSTP1 |
Glutathione S-transferase P |
3.048e-11 |
0.32
|
| KAPCA_HUMAN |
PRKACA |
cAMP-dependent protein kinase catalytic subunit alpha |
3.597e-11 |
0.36
|
| CBX4_HUMAN |
CBX4 |
E3 SUMO-protein ligase CBX4 |
6.781e-11 |
0.39
|
| LGUL_YEAST |
GLO1 |
Lactoylglutathione lyase |
8.191e-11 |
0.29
|
| NOS1_RAT |
Nos1 |
Nitric oxide synthase, brain |
1.062e-10 |
0.37
|
| ASH2L_HUMAN |
ASH2L |
Set1/Ash2 histone methyltransferase complex subunit ASH2 |
1.621e-10 |
0.28
|
| RBBP5_HUMAN |
RBBP5 |
Retinoblastoma-binding protein 5 |
1.621e-10 |
0.28
|
| NK2R_RAT |
Tacr2 |
Substance-K receptor |
2.003e-10 |
0.35
|
| CBX8_HUMAN |
CBX8 |
Chromobox protein homolog 8 |
3.215e-10 |
0.31
|
| NOD1_HUMAN |
NOD1 |
Nucleotide-binding oligomerization domain-containing protein 1 |
6.226e-10 |
0.34
|
| ANPRA_HUMAN |
NPR1 |
Atrial natriuretic peptide receptor 1 |
1.1e-09 |
0.34
|
| CXCR4_HUMAN |
CXCR4 |
C-X-C chemokine receptor type 4 |
2.737e-09 |
0.37
|
| R1AB_SARS |
rep |
Replicase polyprotein 1ab |
5.734e-09 |
0.31
|
| AMPN_HUMAN |
ANPEP |
Aminopeptidase N |
8.922e-09 |
0.40
|
| PAPA1_CARPA |
|
Papain |
1.016e-08 |
0.33
|
| OPRK_CAVPO |
OPRK1 |
Kappa-type opioid receptor |
2.601e-08 |
0.42
|
| OPRX_HUMAN |
OPRL1 |
Nociceptin receptor |
3.027e-08 |
0.45
|
| FPRS1_MOUSE |
Fpr-s1 |
Formyl peptide receptor-related sequence 1 |
3.167e-08 |
0.32
|
| O31048_PORGN |
DPP IV |
Dipeptidyl peptidase IV |
3.736e-08 |
0.35
|
| NOS2_HUMAN |
NOS2 |
Nitric oxide synthase, inducible |
4.727e-08 |
0.45
|
| S22A6_RAT |
Slc22a6 |
Solute carrier family 22 member 6 |
5.111e-08 |
0.30
|
| PTN9_HUMAN |
PTPN9 |
Tyrosine-protein phosphatase non-receptor type 9 |
5.273e-08 |
0.35
|
| NOS2_MOUSE |
Nos2 |
Nitric oxide synthase, inducible |
5.387e-08 |
0.36
|
| AMPB_RAT |
Rnpep |
Aminopeptidase B |
7.232e-08 |
0.32
|
| H9B8T9_CAPHI |
CTSB |
Cathepsin B |
9.594e-08 |
0.47
|
| NTR2_RAT |
Ntsr2 |
Neurotensin receptor type 2 |
9.863e-08 |
0.30
|
| TRYB1_HUMAN |
TPSAB1 |
Tryptase alpha/beta-1 |
1.509e-07 |
0.33
|
| CATD_HUMAN |
CTSD |
Cathepsin D |
1.82e-07 |
0.38
|
| FOLH1_RAT |
Folh1 |
Glutamate carboxypeptidase 2 |
1.848e-07 |
0.36
|
| BHMT1_HUMAN |
BHMT |
Betaine--homocysteine S-methyltransferase 1 |
2.68e-07 |
0.28
|
| ITB3_HUMAN |
ITGB3 |
Integrin beta-3 |
2.898e-07 |
0.52
|
| ERAP1_HUMAN |
ERAP1 |
Endoplasmic reticulum aminopeptidase 1 |
3.493e-07 |
0.31
|
| ITA2B_HUMAN |
ITGA2B |
Integrin alpha-IIb |
3.613e-07 |
0.52
|
| GRIA3_HUMAN |
GRIA3 |
Glutamate receptor 3 |
5.631e-07 |
0.30
|
| MEN1_HUMAN |
MEN1 |
Menin |
7.002e-07 |
0.43
|
| PROC_HUMAN |
PROC |
Vitamin K-dependent protein C |
1.033e-06 |
0.35
|
| CAN1_HUMAN |
CAPN1 |
Calpain-1 catalytic subunit |
1.687e-06 |
0.47
|
| NK3R_RAT |
Tacr3 |
Neuromedin-K receptor |
2.645e-06 |
0.32
|
| Q8CGM4_CAVPO |
OPRM1 |
Mu-opioid receptor |
3.273e-06 |
0.32
|
| NK3R_HUMAN |
TACR3 |
Neuromedin-K receptor |
3.433e-06 |
0.31
|
| AKT3_HUMAN |
AKT3 |
RAC-gamma serine/threonine-protein kinase |
3.785e-06 |
0.36
|
| FA7_HUMAN |
F7 |
Coagulation factor VII |
3.883e-06 |
0.32
|
| TPP2_RAT |
Tpp2 |
Tripeptidyl-peptidase 2 |
4.592e-06 |
0.33
|
| NMDZ1_RAT |
Grin1 |
Glutamate receptor ionotropic, NMDA 1 |
5.06e-06 |
0.32
|
| GRPR_MOUSE |
Grpr |
Gastrin-releasing peptide receptor |
5.988e-06 |
0.30
|
| CAN1_PIG |
CAPN1 |
Calpain-1 catalytic subunit |
6.543e-06 |
0.47
|
| NOS3_HUMAN |
NOS3 |
Nitric oxide synthase, endothelial |
6.984e-06 |
0.43
|